Your browser doesn't support javascript.
loading
Correction to: Synergism between the phosphatidylinositol 3-kinase p110ß isoform inhibitor AZD6482 and the mixed lineage kinase 3 inhibitor URMC-099 on the blockade of glioblastoma cell motility and focal adhesion formation.
Zhao, Hua-Fu; Wu, Chang-Peng; Zhou, Xiu-Ming; Diao, Peng-Yu; Xu, Yan-Wen; Liu, Jing; Wang, Jing; Huang, Xian-Jian; Liu, Wen-Lan; Chen, Zhong-Ping; Huang, Guo-Dong; Li, Wei-Ping.
Afiliação
  • Zhao HF; Department of Neurosurgery, Shenzhen Second People's Hospital/The First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, 518035, China.
  • Wu CP; Department of Neurosurgery, Shenzhen Second People's Hospital/The First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, 518035, China.
  • Zhou XM; Department of Neurosurgery, People's Hospital of Longhua District, Shenzhen, 518109, China.
  • Diao PY; Department of Neurosurgery, Shenzhen Second People's Hospital/The First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, 518035, China.
  • Xu YW; Epilepsy Center, Guangdong 999 Brain Hospital, Guangzhou, 510510, China.
  • Liu J; Department of Neurosurgery, Shenzhen Second People's Hospital/The First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, 518035, China.
  • Wang J; Department of Neurosurgery, Shenzhen Second People's Hospital/The First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, 518035, China.
  • Huang XJ; Department of Neurosurgery, Shenzhen Second People's Hospital/The First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, 518035, China.
  • Liu WL; Department of Neurosurgery/Neuro­Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China.
  • Chen ZP; Department of Neurosurgery, Shenzhen Second People's Hospital/The First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, 518035, China.
  • Huang GD; Department of Neurosurgery, Shenzhen Second People's Hospital/The First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, 518035, China.
  • Li WP; Department of Neurosurgery/Neuro­Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China.
Cancer Cell Int ; 21(1): 403, 2021 Jul 28.
Article em En | MEDLINE | ID: mdl-34321007
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article